Literature DB >> 18021086

Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases.

Ola Landgren1, Robert A Kyle.   

Abstract

Multiple myeloma and chronic lymphocytic leukaemia share common biological and clinical features including the presence of defined precursor conditions (monoclonal gammopathy of undetermined significance and monoclonal B-cell lymphocytosis respectively). Here, we discuss evidence from the literature on the potential aetiological roles for genetic and chronic immune stimulatory factors on the pathway from precursor to malignancy. Also, we speculate on the relationship between precursor and malignancy and talk about future directions and gaps in the literature.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18021086     DOI: 10.1111/j.1365-2141.2007.06866.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  B-cell clones as early markers for chronic lymphocytic leukemia.

Authors:  Ola Landgren; Maher Albitar; Wanlong Ma; Fatima Abbasi; Richard B Hayes; Paolo Ghia; Gerald E Marti; Neil E Caporaso
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

Review 2.  Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.

Authors:  Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Jill Koshiol; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-07-07       Impact factor: 9.941

Review 3.  Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.

Authors:  Barbara Castella; Candida Vitale; Marta Coscia; Massimo Massaia
Journal:  Cell Mol Life Sci       Date:  2011-05-17       Impact factor: 9.261

4.  Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.

Authors:  Sigurdur Y Kristinsson; Jill Koshiol; Magnus Björkholm; Lynn R Goldin; Mary L McMaster; Ingemar Turesson; Ola Landgren
Journal:  J Natl Cancer Inst       Date:  2010-02-24       Impact factor: 13.506

5.  Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

Authors:  Ola Landgren; Robert A Kyle; Ruth M Pfeiffer; Jerry A Katzmann; Neil E Caporaso; Richard B Hayes; Angela Dispenzieri; Shaji Kumar; Raynell J Clark; Dalsu Baris; Robert Hoover; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

Review 6.  Novel therapies in multiple myeloma for newly diagnosed nontransplant candidates.

Authors:  Sigurdur Yngvi Kristinsson; Ola Landgren; Vincent S Rajkumar
Journal:  Cancer J       Date:  2009 Nov-Dec       Impact factor: 3.360

7.  Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.

Authors:  Ola Landgren; Sigurdur Y Kristinsson; Lynn R Goldin; Neil E Caporaso; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Magnus Bjorkholm; Ingemar Turesson
Journal:  Blood       Date:  2009-01-30       Impact factor: 22.113

8.  Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders.

Authors:  Haneef Awan; Viggo Jønsson; Tom B Johannesen; Bernt Ly; Geir E Tjønnfjord
Journal:  Transl Oncogenomics       Date:  2010-03-30

9.  Cancer incidence among pesticide applicators exposed to permethrin in the Agricultural Health Study.

Authors:  Jennifer A Rusiecki; Rahulkumar Patel; Stella Koutros; Laura Beane-Freeman; Ola Landgren; Matthew R Bonner; Joseph Coble; Jay Lubin; Aaron Blair; Jane A Hoppin; Michael C R Alavanja
Journal:  Environ Health Perspect       Date:  2008-11-10       Impact factor: 9.031

10.  Genetic and molecular mechanisms in multiple myeloma: a route to better understand disease pathogenesis and heterogeneity.

Authors:  Marie-Christine Kyrtsonis; Vassiliki Bartzis; Xenophon Papanikolaou; Efstathios Koulieris; George Georgiou; Maria Dimou; Tatiana Tzenou; Panayiotis Panayiotidis
Journal:  Appl Clin Genet       Date:  2010-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.